Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023 Congress

HERZLIYA, Israel and CALGARY, AB, June 22, 2023 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF), a leading innovator in pharmaceutical solutions for Human & Animal health, proudly announces its participation in the 15th International Congress organized by the Executive Committee of the European Association of Veterinary Pharmacology and Toxicology (EAVPT), in … Read more

InnoCan Pharma Submits New Patent Applications for Advanced Pain Relief Technology

The Patent Application is in line with Innocan’s Strategy to Expand the Scope of its Combined Magnesium and Cannabis Topical Solution HERZLIYA, Israel and CALGARY, AB, June 12, 2023 /PRNewswire/ — InnoCan Pharma Corporation (CSE:INNO) (“Innocan Pharma” or the “Company”), a pharmaceutical technology company leveraging its novel cannabis-based therapeutics portfolio of targeted healing products, has announced the … Read more